Glucotrack, INC. 8-K Filing
Ticker: GCTK · Form: 8-K · Filed: Mar 27, 2026 · CIK: 0001506983
| Field | Detail |
|---|---|
| Company | Glucotrack, INC. (GCTK) |
| Form Type | 8-K |
| Filed Date | Mar 27, 2026 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Glucotrack, INC. (ticker: GCTK) to the SEC on Mar 27, 2026.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (ch registered Common Stock, par value $0.001 per share GCTK The Nasdaq Stock Mar).
How long is this filing?
Glucotrack, INC.'s 8-K filing is 2 pages with approximately 491 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 491 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2026-03-27 08:25:24
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share GCTK The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 23KB
- ex99-1_001.jpg (GRAPHIC) — 11KB
- 0001493152-26-013095.txt ( ) — 245KB
- gctk-20260327.xsd (EX-101.SCH) — 3KB
- gctk-20260327_lab.xml (EX-101.LAB) — 33KB
- gctk-20260327_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 27, 2026 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer